Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.8 USD | -0.71% |
|
-2.44% | -1.41% |
05-15 | Transcript : Aytu BioPharma, Inc., Q3 2024 Earnings Call, May 15, 2024 | |
05-15 | Aytu BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.41% | 16.72M | |
+61.53% | 848B | |
+33.48% | 627B | |
-3.66% | 363B | |
+15.06% | 318B | |
+9.18% | 299B | |
+11.90% | 234B | |
+16.24% | 225B | |
+15.67% | 179B | |
+2.47% | 167B |
- Stock Market
- Equities
- AYTU Stock
- News Aytu BioPharma, Inc.
- Cantor Fitzgerald Lowers Aytu BioPharma's Price Target to $5 From $11, Maintains Overweight Rating